Works matching AU Piha-Paul, Sarina

Results: 106
    1
    2
    3
    4

    Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial.

    Published in:
    Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 2, p. 89, doi. 10.36401/JIPO-24-17
    By:
    • Nardo, Mirella;
    • Gouda, Mohamed A.;
    • Reilley, Matthew J.;
    • Biter, Amadeo B.;
    • Lim, Joann;
    • Bean, Stacie A.;
    • Nguyen, Ly M.;
    • Bhosale, Priya R.;
    • Ager, Casey R.;
    • Couillault, Coline A.;
    • Piha-Paul, Sarina A.;
    • Fu, Siqing;
    • Tsimberidou, Apostolia M.;
    • Yap, Timothy A.;
    • Aung Naing;
    • Rodon, Jordi;
    • Subbiah, Vivek;
    • Karp, Daniel D.;
    • Curran, Michael A.;
    • Hong, David S.
    Publication type:
    Article
    5

    Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket Trial.

    Published in:
    Clinical Lung Cancer, 2025, v. 26, n. 3, p. 191, doi. 10.1016/j.cllc.2024.12.003
    By:
    • Goldman, Jonathan W.;
    • Bueno, Alejandro Martinez;
    • Dooms, Christophe;
    • Jhaveri, Komal;
    • de Miguel, Maria;
    • Piha-Paul, Sarina A.;
    • Unni, Nisha;
    • Zick, Aviad;
    • Mahipal, Amit;
    • Suga, J. Marie;
    • Naltet, Charles;
    • Antoñanzas, Monica;
    • Crown, John;
    • Bebchuk, Judith;
    • Eli, Lisa D.;
    • Lowenthal, Beth H.;
    • Mahalingam, Devalingam
    Publication type:
    Article
    6

    Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkz093
    By:
    • Piha-Paul, Sarina A;
    • Hann, Christine L;
    • French, Christopher A;
    • Cousin, Sophie;
    • Braña, Irene;
    • Cassier, Phillippe A;
    • Moreno, Victor;
    • Bono, Johann S de;
    • Harward, Sara Duckworth;
    • Ferron-Brady, Geraldine;
    • Barbash, Olena;
    • Wyce, Anastasia;
    • Wu, Yuehui;
    • Horner, Thierry;
    • Annan, Meg;
    • Parr, Nigel J;
    • Prinjha, Rabinder K;
    • Carpenter, Christopher L;
    • Hilton, John;
    • Hong, David S
    Publication type:
    Article
    7

    Analysis of MET Genetic Aberrations in Patients With Breast Cancer at MD Anderson Phase I Unit.

    Published in:
    Clinical Breast Cancer, 2014, v. 14, n. 6, p. 468, doi. 10.1016/j.clbc.2014.06.001
    By:
    • Debora, de Melo Gagliato;
    • Fontes Jardim, Denis L.;
    • Falchook, Gerald;
    • Tang, Chad;
    • Zinner, Ralph;
    • Wheler, Jennifer J.;
    • Janku, Filip;
    • Subbiah, Vivek;
    • Piha-Paul, Sarina A.;
    • Fu, Siqing;
    • Hess, Kenneth;
    • Roy-Chowdhuri, Sinchita;
    • Moulder, Stacy;
    • Gonzalez-Angulo, Ana M.;
    • Meric-Bernstam, Funda;
    • Hong, David S.
    Publication type:
    Article
    8

    Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational Study.

    Published in:
    2019
    By:
    • George, Goldy C;
    • Iwuanyanwu, Eucharia C;
    • Buford, Adrianna S;
    • Piha-Paul, Sarina A;
    • Subbiah, Vivek;
    • Fu, Siqing;
    • Karp, Daniel D;
    • Pant, Shubham;
    • Hinojosa, Christina O;
    • Hess, Kenneth R;
    • Cleeland, Charles S;
    • Bernstam, Elmer V;
    • Meric-Bernstam, Funda;
    • Hong, David S
    Publication type:
    journal article
    9

    A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies.

    Published in:
    OncoTargets & Therapy, 2021, v. 14, p. 3037, doi. 10.2147/OTT.S291801
    By:
    • Piha-Paul, Sarina A;
    • Dumbrava, Ecaterina E;
    • Nair, Binoj C;
    • Xiong, Wendy;
    • Xu, Li;
    • Mostorino, Rosa;
    • Subbiah, Vivek;
    • Tannir, Nizar;
    • Fu, Siqing;
    • Naing, Aung;
    • Janku, Filip;
    • Karp, Daniel D;
    • Patel, Shreyaskumar;
    • Daw, Najat C;
    • Hong, David;
    • Meric-Bernstam, Funda;
    • Zinner, Ralph
    Publication type:
    Article
    10

    Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials.

    Published in:
    Clinical Genitourinary Cancer, 2022, v. 20, n. 1, p. e16, doi. 10.1016/j.clgc.2021.07.004
    By:
    • Alhalabi, Omar;
    • Hahn, Andrew W.;
    • Msaouel, Pavlos;
    • Meric-Bernstam, Funda;
    • Wilson, Nathaniel;
    • Aung Naing;
    • Piha-Paul, Sarina;
    • Janku, Filip;
    • Pant, Shubham;
    • Yap, Timothy A.;
    • Hong, David S.;
    • Siqing Fu;
    • Karp, Daniel;
    • Beltran, Kimberly;
    • Campbell, Erick;
    • Hung Le;
    • Campbell, Matthew T.;
    • Shah, Amishi;
    • Tannir, Nizar M.;
    • Siefker-Radtke, Arlene
    Publication type:
    Article
    11
    12

    Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12669-5
    By:
    • Yao, Shuyang;
    • Meric-Bernstam, Funda;
    • Hong, David;
    • Janku, Filip;
    • Naing, Aung;
    • Piha-Paul, Sarina Anne;
    • Tsimberidou, Apostolia Maria;
    • Karp, Daniel;
    • Subbiah, Vivek;
    • Yap, Timothy Anthony;
    • Ahnert, Jordi Rodon;
    • Pant, Shubham;
    • Dumbrava, Ecaterina E Ileana;
    • Wathoo, Chetna;
    • Campbell, Erick;
    • Yu, Lihou;
    • Yamamura, Yuko;
    • Fu, Siqing
    Publication type:
    Article
    13
    14
    15

    Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.

    Published in:
    2019
    By:
    • Bhatty, Minny;
    • Kato, Shumei;
    • Piha‐Paul, Sarina A.;
    • Naing, Aung;
    • Subbiah, Vivek;
    • Huang, Helen J.;
    • Karp, Daniel D.;
    • Tsimberidou, Apostolia M.;
    • Zinner, Ralph G.;
    • Hwu, Wen‐Jen;
    • Javle, Milind;
    • Patel, Sapna P.;
    • Hu, Mimi I.;
    • Varadhachary, Gauri R.;
    • Conley, Anthony P.;
    • Ramzanali, Nishma M.;
    • Holley, Veronica R.;
    • Kurzrock, Razelle;
    • Meric‐Bernstam, Funda;
    • Kwang Chae, Young
    Publication type:
    journal article
    16
    17

    Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 14, p. 2164, doi. 10.1002/cncr.28701
    By:
    • Hong, David S.;
    • Garrido‐Laguna, Ignacio;
    • Ekmekcioglu, Suhendan;
    • Falchook, Gerald S.;
    • Naing, Aung;
    • Wheler, Jennifer J.;
    • Fu, Siqing;
    • Moulder, Stacy L.;
    • Piha‐Paul, Sarina;
    • Tsimberidou, Apostolia M.;
    • Wen, YueJin;
    • Culotta, Kirk S.;
    • Anderes, Kenna;
    • Davis, Darren W.;
    • Liu, Wen;
    • George, Goldy C.;
    • Camacho, Luis H.;
    • Percy Ivy, Susan;
    • Kurzrock, Razelle
    Publication type:
    Article
    18

    Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit.

    Published in:
    Oncology, 2017, v. 92, n. 1, p. 14, doi. 10.1159/000449505
    By:
    • Kinahan, Holly;
    • Maiti, abhishek;
    • Hess, Kenneth;
    • Dempsey, Jennifer;
    • Beatty, Laura;
    • Baldwin, Sarah;
    • Hong, David S.;
    • Naing, aung;
    • Fu, Siqing;
    • Tsimberidou, apostolia M.;
    • Piha-Paul, Sarina;
    • Janku, Filip;
    • Karp, Daniel;
    • Reddy, Suresh;
    • Yennu, Sriram;
    • Epner, Daniel;
    • Bruera, Eduardo;
    • Meric-Bernstam, Funda;
    • Falchook, Gerald;
    • Subbiah, Vivek
    Publication type:
    Article
    19

    Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.

    Published in:
    Oncology, 2016, v. 91, n. 6, p. 348, doi. 10.1159/000449204
    By:
    • Subbiah, Vivek;
    • Holmes, Oliver;
    • Gowen, Kyle;
    • Spritz, Daniel;
    • amini, Behrang;
    • Wang, Wei-Lien;
    • Schrock, alexa B.;
    • Meric-Bernstam, Funda;
    • Zinner, Ralph;
    • Piha-Paul, Sarina;
    • Zarzour, Maria;
    • Elvin, Julia a.;
    • Erlich, Rachel L.;
    • Stockman, David L.;
    • Vergilio, Jo-anne;
    • Suh, James H.;
    • Stephens, Philip J.;
    • Miller, Vincent;
    • Ross, Jeffrey S.;
    • ali, Siraj M.
    Publication type:
    Article
    20

    A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma.

    Published in:
    Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 4, p. 247, doi. 10.36401/JIPO-24-3
    By:
    • Gouda, Mohamed A.;
    • Stephen, Bettzy;
    • Tian, Yanyan;
    • Alshawa, Anas;
    • Onwugaje, Dilichukwu O. Chudy;
    • Albittar, Aya;
    • Yali Yang;
    • Zarifa, Abdulrazzak;
    • Yilmaz, Bulent;
    • Gurses, Serdar;
    • Sprenger, Ashabari;
    • Derbala, Mohamed H.;
    • Brink, Amanda;
    • How, Jeffrey Andrew;
    • Moyers, Justin;
    • Piha-Paul, Sarina A.;
    • Hong, David S.;
    • Meric-Bernstam, Funda;
    • Patel, Sapna P.;
    • Oliva, Isabella Glitza
    Publication type:
    Article
    21

    A Decision Support Framework for Genomically Informed Investigational Cancer Therapy.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 7, p. 1, doi. 10.1093/jnci/djv098
    By:
    • Meric-Bernstam, Funda;
    • Johnson, Amber;
    • Holla, Vijaykumar;
    • Bailey, Ann Marie;
    • Brusco, Lauren;
    • Chen, Ken;
    • Routbort, Mark;
    • Patel, Keyur P.;
    • Zeng, Jia;
    • Kopetz, Scott;
    • Davies, Michael A.;
    • Piha-Paul, Sarina A.;
    • Hong, David S.;
    • Eterovic, Agda Karina;
    • Tsimberidou, Apostolia M.;
    • Broaddus, Russell;
    • Bernstam, Elmer V.;
    • Shaw, Kenna R.;
    • Mendelsohn, John;
    • Mills, Gordon B.
    Publication type:
    Article
    22

    A decision support framework for genomically informed investigational cancer therapy.

    Published in:
    2015
    By:
    • Meric-Bernstam, Funda;
    • Johnson, Amber;
    • Holla, Vijaykumar;
    • Bailey, Ann Marie;
    • Brusco, Lauren;
    • Chen, Ken;
    • Routbort, Mark;
    • Patel, Keyur P;
    • Zeng, Jia;
    • Kopetz, Scott;
    • Davies, Michael A;
    • Piha-Paul, Sarina A;
    • Hong, David S;
    • Eterovic, Agda Karina;
    • Tsimberidou, Apostolia M;
    • Broaddus, Russell;
    • Bernstam, Elmer V;
    • Shaw, Kenna R;
    • Mendelsohn, John;
    • Mills, Gordon B
    Publication type:
    journal article
    23

    SU2C Phase Ib Study of Paclitaxel and MK-2206 in Advanced Solid Tumors and Metastatic Breast Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 3, p. 1, doi. 10.1093/jnci/dju493
    By:
    • Gonzalez-Angulo, Ana M.;
    • Krop, Ian;
    • Akcakanat, Argun;
    • Huiqin Chen;
    • Shuying Liu;
    • Yisheng Li;
    • Culotta, Kirk S.;
    • Tarco, Emily;
    • Piha-Paul, Sarina;
    • Moulder-Thompson, Stacy;
    • Velez-Bravo, Vivianne;
    • Sahin, Aysegul A.;
    • Doyle, Laurence A.;
    • Kim-Anh Do;
    • Winer, Eric P.;
    • Mills, Gordon B.;
    • Kurzrock, Razelle;
    • Meric-Bernstam, Funda
    Publication type:
    Article
    24
    25

    Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36399-y
    By:
    • Harding, James J.;
    • Piha-Paul, Sarina A.;
    • Shah, Ronak H.;
    • Murphy, Jessica J.;
    • Cleary, James M.;
    • Shapiro, Geoffrey I.;
    • Quinn, David I.;
    • Braña, Irene;
    • Moreno, Victor;
    • Borad, Mitesh;
    • Loi, Sherene;
    • Spanggaard, Iben;
    • Park, Haeseong;
    • Ford, James M.;
    • Arnedos, Mónica;
    • Stemmer, Salomon M.;
    • de la Fouchardiere, Christelle;
    • Fountzilas, Christos;
    • Zhang, Jie;
    • DiPrimeo, Daniel
    Publication type:
    Article
    26

    Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36399-y
    By:
    • Harding, James J.;
    • Piha-Paul, Sarina A.;
    • Shah, Ronak H.;
    • Murphy, Jessica J.;
    • Cleary, James M.;
    • Shapiro, Geoffrey I.;
    • Quinn, David I.;
    • Braña, Irene;
    • Moreno, Victor;
    • Borad, Mitesh;
    • Loi, Sherene;
    • Spanggaard, Iben;
    • Park, Haeseong;
    • Ford, James M.;
    • Arnedos, Mónica;
    • Stemmer, Salomon M.;
    • de la Fouchardiere, Christelle;
    • Fountzilas, Christos;
    • Zhang, Jie;
    • DiPrimeo, Daniel
    Publication type:
    Article
    27

    A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 2, p. 107, doi. 10.1007/s00280-023-04545-4
    By:
    • Piha-Paul, Sarina A.;
    • Tseng, Chieh;
    • Tran, Hai T.;
    • Gao, Meng;
    • Karp, Daniel D.;
    • Subbiah, Vivek;
    • Tsimberidou, Apostolia Maria;
    • Kawedia, Jitesh D.;
    • Fu, Siqing;
    • Pant, Shubham;
    • Yap, Timothy A.;
    • Morris, Van K.;
    • Kee, Bryan K.;
    • Blum Murphy, Mariela;
    • Lim, JoAnn;
    • Meric-Bernstam, Funda
    Publication type:
    Article
    28

    Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 825, doi. 10.1007/s00280-021-04329-8
    By:
    • Akce, Mehmet;
    • El-Khoueiry, Anthony;
    • Piha-Paul, Sarina A.;
    • Bacque, Emeline;
    • Pan, Peng;
    • Zhang, Zhi-Yi;
    • Ewesuedo, Reginald;
    • Gupta, Divya;
    • Tang, Yongqiang;
    • Milton, Ashley;
    • Zajic, Stefan;
    • Judson, Patricia L.;
    • O'Bryant, Cindy L.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35

    Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies.

    Published in:
    Scientific Reports, 2016, p. 35448, doi. 10.1038/srep35448
    By:
    • Subbiah, Vivek;
    • Hess, Kenneth R.;
    • Khawaja, Muhammad Rizwan;
    • Wagner, Michael J.;
    • Tang, Chad;
    • Naing, Aung;
    • Fu, Siqing;
    • Janku, Filip;
    • Piha-Paul, Sarina;
    • Tsimberidou, Apostolia M.;
    • Herzog, Cynthia E.;
    • Ludwig, Joseph A.;
    • Patel, Shreyaskumar;
    • Ravi, Vinod;
    • Benjamin, Robert S.;
    • Meric-Bernstam, Funda;
    • Hong, David S.
    Publication type:
    Article
    36

    Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.

    Published in:
    PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0189848
    By:
    • O’Neil, Bert H.;
    • Wallmark, John M.;
    • Lorente, David;
    • Elez, Elena;
    • Raimbourg, Judith;
    • Gomez-Roca, Carlos;
    • Ejadi, Samuel;
    • Piha-Paul, Sarina A.;
    • Stein, Mark N.;
    • Abdul Razak, Albiruni R.;
    • Dotti, Katia;
    • Santoro, Armando;
    • Cohen, Roger B.;
    • Gould, Marlena;
    • Saraf, Sanatan;
    • Stein, Karen;
    • Han, Sae-Won
    Publication type:
    Article
    37

    Associations between the gut microbiome and fatigue in cancer patients.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84783-9
    By:
    • Hajjar, Joud;
    • Mendoza, Tito;
    • Zhang, Liangliang;
    • Fu, Siqing;
    • Piha-Paul, Sarina A.;
    • Hong, David S.;
    • Janku, Filip;
    • Karp, Daniel D.;
    • Ballhausen, Alexej;
    • Gong, Jing;
    • Zarifa, Abdulrazzak;
    • Peterson, Christine B.;
    • Meric-Bernstam, Funda;
    • Jenq, Robert;
    • Naing, Aung
    Publication type:
    Article
    38
    39
    40
    41
    42

    Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 3, p. 400, doi. 10.1002/cncr.35063
    By:
    • Knisely, Anne;
    • Ahmed, Jibran;
    • Stephen, Bettzy;
    • Piha‐Paul, Sarina A.;
    • Karp, Daniel;
    • Zarifa, Abdulrazzak;
    • Fu, Siqing;
    • Hong, David Sanghyun;
    • Rodon Ahnert, Jordi;
    • Yap, Timothy A.;
    • Tsimberidou, Apostolia M.;
    • Alshawa, Anas;
    • Dumbrava, Ecaterina E.;
    • Yang, Yali;
    • Song, Juhee;
    • Meric‐Bernstam, Funda;
    • Jazaeri, Amir A.;
    • Naing, Aung
    Publication type:
    Article
    43

    Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 14, p. 2201, doi. 10.1002/cncr.34773
    By:
    • Nelson, Blessie Elizabeth;
    • Saleem, Sadia;
    • Damodaran, Senthil;
    • Somaiah, Neeta;
    • Piha‐Paul, Sarina;
    • Moore, Julia Ann;
    • Yilmaz, Bulent;
    • Ogbonna, Deby;
    • Karp, Daniel D.;
    • Dumbrava, Ecaterina;
    • Tsimberidou, Apostolia M.;
    • Hong, David S.;
    • Rodon Ahnert, Jordi;
    • Milton, Denái R.;
    • Zheng, Xiaofeng;
    • Booser, Daniel J.;
    • Ibrahim, Nuhad K.;
    • Conley, Anthony P.;
    • Bhosale, Priya;
    • Rojas Hernandez, Cristhiam M.
    Publication type:
    Article
    44

    Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.

    Published in:
    2022
    By:
    • Ravi, Vinod;
    • Subramaniam, Aparna;
    • Zheng, Jing;
    • Amini, Behrang;
    • Trinh, Van A.;
    • Joseph, Jocelyn;
    • Mennel, Robert G.;
    • Bishop, Andrew J.;
    • Sturgis, Erich M.;
    • Goepfert, Ryan P.;
    • Yalamanchili, Sudha;
    • Botello, Gilberto;
    • Stephen, Bettzy;
    • Piha‐Paul, Sarina A.;
    • Patel, Anisha B.;
    • Lazar, Alexander J.;
    • Conley, Anthony P.;
    • Benjamin, Robert S.;
    • Patel, Shreyaskumar R.;
    • Futreal, Phillip A.
    Publication type:
    journal article
    45
    46

    Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study.

    Published in:
    2020
    By:
    • Mehnert, Janice M.;
    • Bergsland, Emily;
    • O'Neil, Bert H.;
    • Santoro, Armando;
    • Schellens, Jan H. M.;
    • Cohen, Roger B.;
    • Doi, Toshihiko;
    • Ott, Patrick A.;
    • Pishvaian, Michael J.;
    • Puzanov, Igor;
    • Aung, Kyaw L.;
    • Hsu, Chiun;
    • Le Tourneau, Christophe;
    • Hollebecque, Antoine;
    • Élez, Elena;
    • Tamura, Kenji;
    • Gould, Marlena;
    • Yang, Ping;
    • Stein, Karen;
    • Piha‐Paul, Sarina A.
    Publication type:
    journal article
    47
    48

    IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.

    Published in:
    2017
    By:
    • Ayers, Mark;
    • Lunceford, Jared;
    • Nebozhyn, Michael;
    • Murphy, Erin;
    • Loboda, Andrey;
    • Kaufman, David R.;
    • Albright, Andrew;
    • Cheng, Jonathan D.;
    • Kang, S. Peter;
    • Shankaran, Veena;
    • Piha-Paul, Sarina A.;
    • Yearley, Jennifer;
    • Seiwert, Tanguy Y.;
    • Ribas, Antoni;
    • McClanahan, Terrill K.
    Publication type:
    journal article
    49

    First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.

    Published in:
    Oncologist, 2024, v. 29, n. 4, p. e514, doi. 10.1093/oncolo/oyad338
    By:
    • Piha-Paul, Sarina A;
    • Xu, Binghe;
    • Dumbrava, Ecaterina E;
    • Fu, Siqing;
    • Karp, Daniel D;
    • Meric-Bernstam, Funda;
    • Hong, David S;
    • Rodon, Jordi A;
    • Tsimberidou, Apostolia M;
    • Raghav, Kanwal;
    • Ajani, Jaffer A;
    • Conley, Anthony P;
    • Mott, Frank;
    • Fan, Ying;
    • Fan, Jean;
    • Peng, Peng;
    • Wang, Hui;
    • Ni, Shumao;
    • Sun, Caixia;
    • Qiang, Xiaoyan
    Publication type:
    Article
    50